For: | Coluccio C, Begini P, Marzano A, Pellicelli A, Imperatrice B, Anania G, Delle Fave G, Marignani M. Hepatitis B in patients with hematological diseases: An update. World J Hepatol 2017; 9(25): 1043-1053 [PMID: 28951776 DOI: 10.4254/wjh.v9.i25.1043] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i25/1043.htm |
Number | Citing Articles |
1 |
Chaoyu Wang, Bing Xia, Qiaoyang Ning, Haifeng Zhao, Hongliang Yang, Zhigang Zhao, Xiaofang Wang, Yafei Wang, Yong Yu, Yizhuo Zhang. High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin’s lymphoma in China. Annals of Hematology 2018; 97(3): 453 doi: 10.1007/s00277-017-3188-2
|
2 |
Arturo Ciccullo, F. R. Ponziani, E. Maiolo, F. Pallavicini, M. Pompili. Late reactivation of hepatitis B virus after rituximab-containing chemotherapy for mantle cell lymphoma: a case report. Infection 2019; 47(2): 313 doi: 10.1007/s15010-018-1242-1
|
3 |
Caterina Sagnelli, Mariantonietta Pisaturo, Federica Calò, Salvatore Martini, Evangelista Sagnelli, Nicola Coppola. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention. World Journal of Gastroenterology 2019; 25(26): 3299-3312 doi: 10.3748/wjg.v25.i26.3299
|
4 |
Dao-guang Chen, Gang Chen, Chang Wang, Long-feng Ke, Hui Wu, Hong-ming He, Yu Yang, Yan-ping Chen. Clinicopathological and prognostic features of hepatitis B virus-associated diffuse large B-cell lymphoma: a single-center retrospective study in China. Infectious Agents and Cancer 2021; 16(1) doi: 10.1186/s13027-021-00396-x
|
5 |
Claudia Giordano, Marco Picardi, Novella Pugliese, Annamaria Vincenzi, Davide Pio Abagnale, Laura De Fazio, Maria Luisa Giannattasio, Carmina Fatigati, Mauro Ciriello, Alessia Salemme, Giada Muccioli Casadei, Elena Vigliar, Massimo Mascolo, Giancarlo Troncone, Fabrizio Pane. Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1130899
|
6 |
Lan-Ying He, Yu-Lan Wang, Xu Tian, Wei-Qing Chen. The association of hepatitis B virus screening and antiviral prophylaxis with adverse liver outcomes in Chinese cancer patients undergoing chemotherapy. Medicine 2020; 99(14): e19647 doi: 10.1097/MD.0000000000019647
|
7 |
Xing Cao, Yafei Wang, Panyun Li, Wei Huang, Xiaojuan Lu, Hongda Lu. HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.685706
|
8 |
Ibrahim M. Sayed, Mohamed Ismail Seddik, Marwa A. Gaber, Saber H. Saber, Sahar A. Mandour, Mohamed A. El-Mokhtar. Replication of Hepatitis E Virus (HEV) in Primary Human-Derived Monocytes and Macrophages In Vitro. Vaccines 2020; 8(2): 239 doi: 10.3390/vaccines8020239
|
9 |
Gonçalo Pereira Cruz, Celene Sargento, Maria Conceição Ventura, Joaquim Oliveira, José Saraiva da Cunha. Occult hepatitis B infection by a recombinant D/C virus in an immunosuppressed patient. IDCases 2020; 19: e00671 doi: 10.1016/j.idcr.2019.e00671
|
10 |
Hongming Nie, Zhaohe Mei, Rong Wang, Binbin Zhao, Yueqiu Gao, Jianjie Chen, Lingtai Wang. Bushen recipe and its disassembled prescriptions inhibit inflammation of liver injury associated with Concanavalin A through Toll‑like receptor 3/9 signaling pathway. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9082
|
11 |
Anna H. Schuh, Nilima Parry‐Jones, Niamh Appleby, Adrian Bloor, Claire E. Dearden, Christopher Fegan, George Follows, Christopher P. Fox, Sunil Iyengar, Ben Kennedy, Helen McCarthy, Helen M. Parry, Piers Patten, Andrew R. Pettitt, Ingo Ringshausen, Renata Walewska, Peter Hillmen. Guideline for the treatment of chronic lymphocytic leukaemia. British Journal of Haematology 2018; 182(3): 344 doi: 10.1111/bjh.15460
|
12 |
Yiqi Liu, Reyizha Nuersulitan, Chi Zhang, Na Huo, Jun Li, Yuqin Song, Jun Zhu, Weiping Liu, Hong Zhao. Steady Decline of HBV DNA Load under NAs in Lymphoma Patients and a Higher Level of qAnti-HBc Predict HBV Reactivation. Journal of Clinical Medicine 2023; 13(1): 23 doi: 10.3390/jcm13010023
|
13 |
Man-Fung Yuen, Ding-Shinn Chen, Geoffrey M. Dusheiko, Harry L. A. Janssen, Daryl T. Y. Lau, Stephen A. Locarnini, Marion G. Peters, Ching-Lung Lai. Hepatitis B virus infection. Nature Reviews Disease Primers 2018; 4(1) doi: 10.1038/nrdp.2018.35
|
14 |
Alessandra Zannella, Massimo Marignani, Paola Begini. Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management. Viruses 2019; 11(9): 858 doi: 10.3390/v11090858
|